We have established an adipose tissue bank that is the only one of its kind in Lithuania, for processing, storage and distribution of stromal vascular fraction cells from adipose tissue. It is also the country’s only tissue bank that carries out activities in premises equipped in accordance with Good Manufacturing Practice requirements. Our patented technology of extracted cells from adipose tissue has huge regenerative potential and can restore functions of the damaged tissues. These cells can be used even after 20 years after their preparation.
Currently, we are the only laboratory in the Baltic States capable of producing ATMPs. In addition, we produce dendritic cell vaccine for cancer immunotherapy, offering a supplementary treatment for cancer that activates the patient’s immune system to fight the disease.
To develop the field of individual therapies in Lithuania, we have continually invested in research, and have cooperated in scientific projects with local and foreign biotechnology companies, scientific institutions and other tissue banks. We take an extremely responsible approach to the preparation, training and internships of specialists working in the field of cell therapies.